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Background/aim: Infertility is a main health issue. The human Y chromosome contains essential genes for spermatogenesis, especially
those located on four major intervals defined as AZFa, AZFb, AZFc, and AZFd. A partial deletion of the AZFc region is reported as a
significant risk factor for oligo-/azoospermia. The main purpose of this study was to investigate the prevalence of partial deletions in the
AZFc region (gr/gr, b1/b3, and b2/b3) in Iranian oligozoospermic candidates for intracytoplasmic sperm injection.
Materials and methods: Multiplex PCR was used to assess the micro and partial deletions in 60 oligozoospermia infertile and 80 fertile
men.
Results: Two cases (3.33%) showed AZFb deletion but no microdeletion was detected in the control samples. In the AZFc region, 20%
of the patients showed deletions, in which 15% and 5% showed gr/gr and b2/b3 deletions, respectively. However, 10% of the healthy
individuals also showed partial deletions, including gr/gr (7.5%) and b2/b3 (2.5%). No significant correlation was detected between the
presence of gr/gr microdeletion in patients and controls (P > 0.05).
Conclusion: Our study showed that the partial AZFc deletions are not associated with male infertility in Iranian subjects.
Key words: Oligozoospermia, gr/gr, b1/b3, b2/b3, partial deletion, intracytoplasmic sperm injection

1. Introduction
Male infertility is characterized as a multifactorial
syndrome with a wide variety of disorders. The etiology of
the disease remains unknown in more than half of infertile
men with a limited prognosis. In many cases, the patient
expresses natural attributes of manhood, but the tests are
unable to produce spermatozoa capable of inseminating
oocytes. Today, couple infertility is identified as a health
problem. According to the World Health Organization in
1987, infertility affects about 10%–15% of all couples, and
approximately 50% of the cases involve the male factor.
In men, infertility is often associated with oligospermia
or azoospermia (1). In general, a high proportion of
male infertility is associated with systemic defects such
as diabetes, obesity, varicoceles, and cystic fibrosis or
infections such as mumps and herpes. Unbalanced
levels of gonadotropin hormones such as testosterone,
dihydrotestosterone, follicle stimulating hormone, and
luteinizing hormone are amongst other causes of infertility.
* Correspondence: massoudh@nigeb.ac.ir

Not only has the production of hormones, the structure
of testis, ejaculation, and spermatozoa had reverse effects
on the chance of pregnancy, but genetic abnormalities
also have a major influence on infertility. Genetic
abnormalities in infertile men are ten times more likely
than in the general population (2). The Y chromosome
carries different genes essential for spermatogenesis.
This concept was first presented by Tiepolo and Zuffardi
(3). Their molecular studies on Y chromosome deletions
led to the diagnosis of azoospermia factors (AZF) in
the Yq11.2 region (3). The Y-chromosome euchromatin
region embraces a distinct family of genes essential for
spermatogenesis that are usually attributed to AZF. The
deletions that occur in the three regions of Yq11, shown as
AZFa, AZFb, and AZFc, seem to be associated with special
defects in spermatogenesis (4).
AZFc is located on the distal region of the deletion
interval 6 (6C-6E) of the Y chromosome. AZF deletion
districts have a high prevalence, as seen in 2%–10% of
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men with severe oligozoospermia or azoospermia (3).
The expansion of this area is around 5.3 Mb and includes
7 gene groups involved in spermatogenesis (5). Fractional
analysis of the AZF regions using new molecular markers
proved three types of microdeletion known as gr/gr, b1/
b2, and b1/b3 (6). The correlation between relative AZF
deletion and infertility is unknown (7).
Some of these deletions have minor effects on infertility,
while others have high risks linked with spermatogenesis
defects. As suggested by Yen (2001), the b1/b3 deletion
takes place in the proximal region of AZFc, with a very low
prevalence, where only a small number of spermatozoa in
infertile men have been observed (8). The relationship
between this deletion and infertility remains unknown.
The second relative deletion (gr/gr) removes a proximal
1.6 Mb segment from the AZFc region containing two
copies of DAZ gene clusters (DAZ 1, 2) (7,9). Vogt et
al. detected this deletion in 5 out of 63 oligospermic
samples, compared to 107 normal subjects. Therefore, they
suggested that gr/gr deletion may be responsible for the
reduced sperm count (10).
At least two further AZFc partial microdeletions,
such as b1/b3 and b2/b3 deletions, were responsible for
spermatogenesis, in which the effect of b1/b3 deletion
remains unidentified with a lower frequency than gr/
gr deletion in the general population. Just like gr/gr
deletions, b2/b3 deletions are also associated with specific
Y chromosome deletion. The b2/b3 deletion was first
described in 2004 by the Sjoerd Repping group. They
screened 1563 men and in 25 of them the SY1191 marker
was eliminated, thus indicating that b2/b3 deletions
probably originated from a gr/gr inversion and later
deletion between the amplicon b2 and b3 (7).
Our objectives were to determine the prevalence
of partial microdeletions of the AZFc region in
oligozoospermic candidates for intracytoplasmic sperm
injection (ICSI) to evaluate their association with
spermatogenic failure, and also to define the genetic
association between partial AZFc deletions in both
infertile patients and controls.

2. Materials and methods
2.1. Specimen collection
Sixty infertile men with sperm concentrations of <20 ×
106 sperm/mL were recruited, having at least 4 duration of
infertility. Male patients with oligozoospermia were from
Yazd Infertility Treatment Center and those with normal
karyotype were selected for this study. Eighty subjects with
proven fertility and normal sperm concentration (>20 ×
106 sperm/mL) were recruited as the controls.
2.2. DNA extraction
Total DNA was isolated from the peripheral blood of the
patients using a QIAGEN DNA extraction kit.
2.3. Molecular screening
Polymerase chain reaction (PCR) was used to detect the
eight different loci corresponding to different primarily
investigated AZF loci, which included AZFa (sY86, sY84),
AZFb (sY134, sY127), AZFc (sY255, sY254), and AZFd
(sY145, sY153). Individual and multiplex-PCRs were set
up preceding the following STSs: individual PCRs (sY86,
sY84), multiplex 1 (sY127, sY254, ZFY), multiplex 2
(sY134, sY255, SRY), and multiplex 3 (sY145, SY153, SRY).
Moreover, two ZFY and SRY primers were used as the
control primers. Further details of the primer sequences
are provided in Tables 1 and 2. The reaction included
50–100 ng of the genomic DNA in 25 µL PCR reaction
mix containing 10 mM Tris HCl (pH 8.3), 50 mM KCl,
1.5 mM MgCl2, 2 mM dNTP, 10 pM of each primer, and
1 unit of Taq DNA polymerase. The initial denaturation
step was at 94 °C for 5 min, followed by 28 cycles of 94 °C
for 30 s, 56 °C for 30 s, and 72 °C for 45 s ending with a
final extension for 5 min at 72 °C. The PCR products were
electrophoresed on 2% agarose gel stained with ethidium
bromide. Then samples without classical AZF deletion
were investigated in order to find gr/gr, b1/b3, and b2/
b3 polymorphisms. The samples lacking partial AZF
microdeletions were examined to find the gr/gr, b1/b3,

Table 1. List of sequence tagged sites (STSs) primers used as control primers.
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STSs

Size (bp)

Sequence

ZFY

495

F: 5´ACCRTCGTACTGACTGTGATTACAC3´
R: 5´GCACYTCTTTGGTATCYGAGAAAGT3´

SRY

472

F: 5´GAATATTCCCGCTCTCCGGA3´
R: 5´GCTGGTGCTCCATTCTTGAG3´

sY142

196

F: 5´AGCTTCTATTCGAGGGCTTC3´
R: 5´CTCTCTGCAATCCCTGACAT3´
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Table 2. List of STSs primers used to screen micro and partial deletions of AZF regions.
STSs

AZF

Size (bp)

Sequence

sY84

AZFa

326

F: 5´AGA AGG GTC TGA AAG CAG GT3´
R: 5´GCC TAC TAC CTG GAG GCT TC3´

sY86

AZFa

320

F: 5´GTG ACA CAC AGA CTA TGC TTC3´
R: 5´ACA CAC AGA GGG ACA ACC CT3´

sY127

AZFb

274

F: 5´GGC TCA CAA ACG AAA AGA AA3´
R: 5´CTG CAG GCA GTA ATA AGG GA3´

sY134

AZFb

301

F: 5´GTC TGC CTC ACC ATA AAA CG3´
R: 5´ACC ACT GCC AAA ACT TTC AA3´

sY254

AZFc

400

F: 5´GGG TGT TAC CAG AAG GCA AA3´
R: 5´GAA CCG TAT CTA CCA AAG CAG C3´

sY255

AZFc

126

F: 5´GTT ACA GGA TTC GGC GTG AT3´
R: 5´CTC GTC ATG TGC AGC CAC3´

sY145

AZFd

125

F: 5´CAA CAC AAA AAC ACT CAT ATACTCG3´
R: 5´GGG CAT TGT ATG TTA ATA AGA GTT3´

sY153

AZFd

135

F: 5´GCA TCC TCA TTT TAT GTC CA3´
R: 5´ATG AGT CAC GAA AAC CCA AC3´

sY1191

AZFc

385

F: 5´CCAGACGTTCTACCCTTTCG3´
R: 5´GAGCCGAGATCCAGTTACCA3´

sY1291

AZFc

527

F: 5´TAAAAGGCAGAACTGCCAGG3´
R: 5´GGGAGAAAAGTTCTGCAACG3´

and b2/b3 polymorphisms. The presence of the mentioned
deletions was evaluated by utilizing a single multiplexPCR performed with two sY1191 and sY1291 STS markers
(Table 2), and also sY142 marker used for detecting the
controls (Table 1). The reaction conditions and PCR
program were similar to the classical AZF as stated before.
Then PCR products were separated on 2% agarose gel. The
gr/gr and b2/b3 deletions were represented respectively by
not being amplified in the PCR products with sY1291 and
sY1191 primers, which results in the amplification of b1/
b3 deletion.
2.4. Ethics statement
Sixty infertile male patients and 80 subjects with proven
fertility were referred to the Yazd Infertility Treatment
Center for diagnosis between January 2007 and November
2011. Documented, written consent was obtained from
the patients as approved for the entire study protocol by
the SMC governing ethics committee at the time.
2.5. Statistical analysis
Fisher’s exact probability test was used with SPSS (version
13) to examine the association between the patient and
control groups; P values < 0.05 were regarded as statistically
significant.

3. Results
The multiplex-PCR analysis was used in order to
determine AZFb and AZFc including gr/gr, b1/b3, and
b2/b3 subdeletions in all subjects. In this study, two
subjects (3.33%) were identified as having l AZFb deletion
in using plus/minus STS analysis of the genomic DNA
recommended by EAA/EMQN (10).
Nine subjects (15%) were found to have gr/gr
subdeletion. However, six controls (7.5%) also showed gr/
gr subdeletions. Fisher’s exact probability test was used
to examine the association of gr/gr deletions and male
infertility. The test revealed P > 0.05. The null hypothesis
was accepted, indicating that there was no significant
association between gr/gr deletions and male infertility.
Three subjects (5%) indicated b2/b3 subdeletions,
while two controls (2.5%) showed b2/b3 subdeletions.
Fisher’s exact probability test was used to examine the
association of b2/b3 deletions and male infertility. The
test revealed P > 0.05. The null hypothesis was accepted,
indicating that there was no significant association
between gr/gr deletions and male infertility. In addition,
the b1/b3 deletion was absent from the both patients and
controls (Table 3).
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Table 3. List of subdeletions (gr/gr, b1/b3, and b2/b3) in the AZFc region.
Partial AZFc deletions

Patients

Controls

P-value

gr/gr

9 (15%)

6(7.5%)

P > 0.05

b1/b3

-*

-*

b2/b3

3 (5%)

2 (2.5%)

P > 0.05

*shows the absence of deletion in both patients and controls.

4. Discussion
It is commonly accepted that Y chromosome microdeletion
is a determining factor in severe spermatogenic disorders.
However, the relationship between AZFc partial deletions
and male sterility is still discussed. In the present study,
the absence of AZFc region deletions in oligozoospermic
patients initiated the investigation for Y chromosome
partial deletions in a number of patients who lacked
classical deletions. As far as these partial deletions were
observed in the general population of infertile patients, it
was thought that they did not have any influence on male
fertility. Many studies have been carried out to detect the
relationship between subdeletions and sterility in recent
years, but the results in different populations were not
identical.
In the present study, gr/gr deletion showed the highest
frequency among the patient and control samples. In the
patient samples, 9 (15%) and 3 (5%) individuals showed
gr/gr and b2/b3 deletion, respectively. However, in the
control population, 6 (7.5%) and 2 (2.5%) individuals
showed gr/gr and b2/b3 deletions, respectively, which
indicated no significant difference between the patient and
control samples (P > 0.05).
Based on the results from the Institute of Reproductive
Medicine, the AZFc region has the highest level of
microdeletions (79%), while the frequency of AZFb, AZFa,
AZFb,c, and AZFa,b,c deletions are 9%, 3%, 6%, and 3%,
respectively (11). However, other authors reported that
the classical AZFb deletions were more common than the
AZFc region in the patients (12,13).
The AZFb microdeletion halts spermatogenesis and
sperm maturation, while AZFc deletion is followed
by phenotypic variations from severe oligospermia to
azoospermia. Partial deletions in AZFc can either lead to
azoospermia or associate with the normal phenotypes.
Therefore, one type of treatment for these individuals
involves ICSI. However, ICSI is considered dangerous for
those born from fathers with Y chromosome abnormalities,
as only 2%–3% of ICSI candidates have microdeletions
on their Y chromosome. It is estimated that if half of
the oligospermia men undergo ICSI, the prevalence
of male infertility will increase two-fold throughout 7
generations when the inherited deletions are passed to
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the offspring (14). Another study showed no significant
difference in the population of fertile men in comparison
to the frequency of these subdeletions in Iranian male
oligozoospermic and azoospermic patients (13). Results of
the present study have shown that deletion frequencies in
Iranian infertile men are different from those of men in
European, Chinese, and Indian populations, which can be
due either to the low number of specimens or the selection
of patients. It was previously thought that partial deletions
do not affect male fertility because these deletions are also
observed in a population of fertile men. However, several
groups evaluated these microdeletions in infertile men in
order to illustrate their close relationship with infertility.
Other studies reported significant correlations of gr/gr
deletions (15–17) and insignificant associations of AZFc
partial deletions with infertility in men (18–22). However,
there are several factors that affect these results, such as
demographic variations, differences in patient selection
values, AZF in variable deletion regions, applying different
STS markers, and environmental effects, and also the
classification method used to define oligospermia with
different amount of sperms varied, i.e. 5 × 106, 2 × 106,
and 1 × 106, where Vog considered 2 × 106 > sperms per
milliliter as an oligospermia standard (23) and in other
studies performed by Carrara (24) and Hellani (25) this
standard was considered 1 × 106 > sperms per milliliter,
which certainly had an important influence on the results
of these studies (26). However, in the present study, the
standard for selecting patients among the oligospermia
men was a sperm count of less than 20 × 106 per milliliter.
The role of gr/gr deletion in infertility and its high rate
of occurrence in the Iranian male population is probably
related to a polymorphic trait of gr/gr deletion in infertility
(18,19,27) or as a genetic factor that affects male fertility by
interactions with other genetic and environmental factors
(6). Visser et al. carried out metaanalysis experiments over
7 studies, observing a higher frequency of gr/gr deletion
in oligozoospermia and azoospermia male patients
compared to the control population. Furthermore, the
amount of sperm in the semen was lower in males with
gr/gr deletion, which is in agreement with our study (28).
A study by Van et al. led to the hypothesis that deletions
can either impair sperm quality or cause devastating
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effects on sperm functionality in fertilization processes,
which will reduce the probability of having a son (29).
Therefore, evaluating Y chromosome deletions is an
important factor in ICSI precounselling sessions. Longterm studies on ICSI children are the most necessary in
men with hypospermatogenesis, where ICSI may lead to
45, XO embryos (30).
In the majority of men with impaired spermatogenesis,
no clear reason can be identified to be responsible for
their infertility. Complete deletion of the Y chromosome
has been well accepted as the major cause of severe
spermatogenesis disorders. However, the relationship
between partial AZFc deletions and male infertility is still
controversial. In recent years, many studies demonstrated
the relationship between these deletions and infertility but
results in different populations varied.

In conclusion, our findings suggest the necessity of
more extensive studies on Y chromosomal rearrangements,
especially the difference in gene function between copies
of AZFc genes, genomic copy number variation, and
screening for AZFc deletions in larger cohorts of both case
and control populations in different ethnic/geographic
origins for better understanding of the contribution of
AZFc deletions in spermatogenesis and its pathology in
male infertility.
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